April 27, 2020 First quarter of 2020:Bayer: Good start to 2020 – activities marked by COVID-19Read more
April 24, 2020 Treatment of COVID-19:Bayer to donate one million tablets of chloroquine for use in ItalyRead more
SPECIALIZED PRESS April 23, 2020 Not intended for U.S. and UK MediaBayer to highlight clinical data on Vitrakvi™ (larotrectinib) and research on investigational AhR inhibitor at AACR 2020 Virtual MeetingRead more
April 21, 2020 Bayer partners with Population Health Research Institute (PHRI) on global clinical research evaluating COVID-19 treatmentsRead more
April 17, 2020 Solidarity in the fight against COVID-19:Bayer to donate EUR 1 million to support the fight against the coronavirus pandemic in FranceRead more
April 17, 2020 Further emergency aid: Bayer to donate EUR 1 million to support the fight against COVID-19 in BrazilRead more
April 14, 2020 An additional article on fighting the corona pandemic:Bayer donates 8 million chloroquine tablets to the German Federal GovernmentRead more
April 8, 2020 Comprehensive aid package:Bayer supports fight against the corona pandemic in Spain with measures totaling approximately 1 million eurosRead more
SPECIALIZED PRESS April 8, 2020 Not intended for U.S. and UK MediaBayer launches pre-filled syringe to administer eye medication Eylea™ in EuropeRead more
SPECIALIZED PRESS March 30, 2020 Not intended for U.S. and UK MediaNubeqa™ (darolutamide) receives EU approval as a new treatment for men with non-metastatic castration-resistant prostate cancerRead more
